@article{126c23e041b94ce38e159d5b13b8564d,
title = "Association Between Cigarette Smoking Frequency and Tobacco Use Disorder in U.S. Adults",
author = "Oliver, \{Jason A.\} and Jonathan Foulds",
note = "Funding Information: JAO is a co-inventor on a provisional patent of a system using machine learning to identify smoking environments from visual images that is unrelated to the submitted work. JF has received grants from the NIH; has previously received a grant, personal fees, and nonfinancial support from Pfizer Inc., unrelated to the submitted work; in the past (>3 years ago), has done paid consulting for pharmaceutical companies involved in manufacturing smoking-cessation medications (e.g., GlaxoSmithKline, Johnson \& Johnson); and has acted as a deposed and compensated expert witness on behalf of plaintiffs suing cigarette manufacturers. Funding Information: This manuscript was prepared using a limited access data set obtained from the National Institute on Alcohol Abuse and Alcoholism. It does not reflect the opinions or views of the National Institute on Alcohol Abuse and Alcoholism or the U.S. government. Additional support was provided by a career development award provided to JAO by the National Institute on Drug Abuse (K23 DA042898). JF is supported by NIH grants (R01 DA048428, U01 DA045517). The funders had no role in the design and conduct of the study; collection, management, analysis, or interpretation of the data; preparation, review, or approval of the manuscript; or the decision to submit the manuscript for publication. JF conceived the project. JAO and JF jointly designed the project. JAO conducted the statistical analysis. JF wrote the initial draft of the manuscript. Both JAO and JF reviewed the manuscript for important intellectual content and approved the submitted version. JAO is a co-inventor on a provisional patent of a system using machine learning to identify smoking environments from visual images that is unrelated to the submitted work. JF has received grants from the NIH; has previously received a grant, personal fees, and nonfinancial support from Pfizer Inc. unrelated to the submitted work; in the past (>3 years ago), has done paid consulting for pharmaceutical companies involved in manufacturing smoking-cessation medications (e.g. GlaxoSmithKline, Johnson \& Johnson); and has acted as a deposed and compensated expert witness on behalf of plaintiffs suing cigarette manufacturers. Funding Information: Additional support was provided by a career development award provided to JAO by the National Institute on Drug Abuse ( K23 DA042898 ). JF is supported by NIH grants ( R01 DA048428 , U01 DA045517 ). ",
year = "2021",
month = may,
doi = "10.1016/j.amepre.2020.10.019",
language = "English (US)",
volume = "60",
pages = "726--728",
journal = "American Journal of Preventive Medicine",
issn = "0749-3797",
publisher = "Elsevier Inc.",
number = "5",
}